Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/NMPA/Abacavir Sulfate Oral Solution

Approved

化学药品

Abacavir Sulfate Oral Solution

ViiV Healthcare BV🇨🇳 National Medical Products Administration

Approval Date: Jun 8, 2021
Approval ID: 8DqlhoEA9Rf
Company: ViiV Healthcare BV
Type: 化学药品

Approval Details

Approval Id: 8DqlhoEA9Rf
Approval Number: 国药准字HJ20150202
Generic Name: 硫酸阿巴卡韦口服溶液
Generic Name En: Abacavir Sulfate Oral Solution
Trade Name: 赛进
Drug Type: 化学药品
Dosage Form: 口服溶液剂
Strength: 240ml:4.8g (20mg/ml), 按C₁₄H₁₈N₆O计
Reg Date: 2021-06-08
Expired Date: 2026-06-07
Company Name: ViiV Healthcare BV
Company Detail Path: /organization/viiv-healthcare-bv

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Jun 8, 2021

Approval ID

8DqlhoEA9Rf

Type

化学药品

Back to NMPA Approvals

赛进 - NMPA Drug Approval Details